Yuhan Yang[Author] - Search Results

Year	Number of Results
2010	1
2011	2
2013	3
2014	3
2015	7
2016	8
2017	7
2018	6
2019	12
2020	25
2021	24
2022	30
2023	41
2024	13

1

Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects.

Chen AN, Luo Y, Yang YH, Fu JT, Geng XM, Shi JP, Yang J. Chen AN, et al. Front Immunol. 2021 Jun 10;12:688910. doi: 10.3389/fimmu.2021.688910. eCollection 2021. Front Immunol. 2021. PMID: 34177945 Free PMC article. Review.

2

Metabolism, metabolites, and macrophages in cancer.

Li M, Yang Y, Xiong L, Jiang P, Wang J, Li C. Li M, et al. Among authors: yang y. J Hematol Oncol. 2023 Jul 25;16(1):80. doi: 10.1186/s13045-023-01478-6. J Hematol Oncol. 2023. PMID: 37491279 Free PMC article. Review.

3

N⁶-methyladenosine-mediated LDHA induction potentiates chemoresistance of colorectal cancer cells through metabolic reprogramming.

Zhang K, Zhang T, Yang Y, Tu W, Huang H, Wang Y, Chen Y, Pan K, Chen Z. Zhang K, et al. Among authors: yang y. Theranostics. 2022 Jun 13;12(10):4802-4817. doi: 10.7150/thno.73746. eCollection 2022. Theranostics. 2022. PMID: 35832094 Free PMC article.

4

M2 Macrophage-Derived Exosomes Promote Angiogenesis and Growth of Pancreatic Ductal Adenocarcinoma by Targeting E2F2.

Yang Y, Guo Z, Chen W, Wang X, Cao M, Han X, Zhang K, Teng B, Cao J, Wu W, Cao P, Huang C, Qiu Z. Yang Y, et al. Mol Ther. 2021 Mar 3;29(3):1226-1238. doi: 10.1016/j.ymthe.2020.11.024. Epub 2020 Nov 20. Mol Ther. 2021. PMID: 33221435 Free PMC article.

5

Fluorinated vectors for gene delivery.

Wan Y, Yang Y, Wu M, Feng S. Wan Y, et al. Among authors: yang y. Expert Opin Drug Deliv. 2022 Nov;19(11):1435-1448. doi: 10.1080/17425247.2022.2131769. Epub 2022 Oct 6. Expert Opin Drug Deliv. 2022. PMID: 36184732 Review.

6

Advances in radiotherapy and immunity in hepatocellular carcinoma.

Yang Y, Xiong L, Li M, Jiang P, Wang J, Li C. Yang Y, et al. J Transl Med. 2023 Aug 4;21(1):526. doi: 10.1186/s12967-023-04386-y. J Transl Med. 2023. PMID: 37542324 Free PMC article. Review.

7

Target immune components to circumvent sorafenib resistance in hepatocellular carcinoma.

Wei S, Wei F, Li M, Yang Y, Zhang J, Li C, Wang J. Wei S, et al. Among authors: yang y. Biomed Pharmacother. 2023 Jul;163:114798. doi: 10.1016/j.biopha.2023.114798. Epub 2023 Apr 28. Biomed Pharmacother. 2023. PMID: 37121146 Free article. Review.

8

Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC.

Sena LA, Kumar R, Sanin DE, Thompson EA, Rosen DM, Dalrymple SL, Antony L, Yang Y, Gomes-Alexandre C, Hicks JL, Jones T, Bowers KA, Eskra JN, Meyers J, Gupta A, Skaist A, Yegnasubramanian S, Luo J, Brennen WN, Kachhap SK, Antonarakis ES, De Marzo AM, Isaacs JT, Markowski MC, Denmeade SR. Sena LA, et al. Among authors: yang y. J Clin Invest. 2022 Dec 1;132(23):e162396. doi: 10.1172/JCI162396. J Clin Invest. 2022. PMID: 36194476 Free PMC article.

9

Artificial intelligence applications in pediatric oncology diagnosis.

Yang Y, Zhang Y, Li Y. Yang Y, et al. Explor Target Antitumor Ther. 2023;4(1):157-169. doi: 10.37349/etat.2023.00127. Epub 2023 Feb 28. Explor Target Antitumor Ther. 2023. PMID: 36937318 Free PMC article. Review.

10

The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment.

Li M, Jiang P, Yang Y, Xiong L, Wei S, Wang J, Li C. Li M, et al. Among authors: yang y. Exp Hematol Oncol. 2023 Dec 8;12(1):103. doi: 10.1186/s40164-023-00464-5. Exp Hematol Oncol. 2023. PMID: 38066523 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

165 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Results by year